...
首页> 外文期刊>Japanese Journal of Pharmacology >Effects of angiotensin-converting enzyme inhibitors on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary disease.
【24h】

Effects of angiotensin-converting enzyme inhibitors on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary disease.

机译:血管紧张素转换酶抑制剂对从患有或未患有慢性阻塞性肺疾病的患者中收集的支气管肺泡灌洗细胞自发或刺激产生活性氧的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

We examined the effects of angiotensin-converting enzyme (ACE) inhibitors on spontaneous or stimulated generation of reactive oxygen species (ROS) by bronchoalveolar lavage (BAL) cells prepared from 6 patients with chronic obstructive pulmonary disease (COPD) and from age-matched control subjects without COPD. The ROS produced by BAL cells were measured by the lucigenin-dependent chemiluminescence method. The application of ACE inhibitors into culture media containing BAL cells inhibited spontaneous and stimulated generation of ROS by BAL cells from COPD patients and control subjects in an ambroxol-concentration-dependent manner. Alacepril, an ACE inhibitor bearing SH-group, inhibited the oxygen radical production and generation by BAL cells from COPD patients in a dose-dependent fashion. Approximately 0.6-0.7 mM of alacepril inhibited 50% of the ROS production by BAL cells from COPD patients, whereas a slightly higher concentration (3 mM) of lisinopril, an ACE inhibitor not bearing an SH-group, was necessary to inhibit the production of ROS. These results suggest that an ACE inhibitor may act as an pulmonary antioxidant in patients with COPD.
机译:我们检查了血管紧张素转化酶(ACE)抑制剂对由6例慢性阻塞性肺疾病(COPD)患者和年龄匹配的对照组制备的支气管肺泡灌洗(BAL)细胞自发或刺激产生的活性氧(ROS)的影响没有COPD的受试者。 BAL细胞产生的ROS通过光黄素依赖性化学发光法测定。 ACE抑制剂在含有BAL细胞的培养基中的应用以Ambroxol浓度依赖的方式抑制了COPD患者和对照对象的BAL细胞自发和刺激产生ROS。 Alacepril,一种带有SH-基团的ACE抑制剂,以剂量依赖的方式抑制了COPD患者的BAL细胞产生的氧自由基。大约0.6-0.7 mM的alacepril抑制了COPD患者的BAL细胞产生的ROS的50%,而抑制不含有SH-基团的ACE抑制剂赖诺普利的浓度略高(3 mM)对于抑制CPS的产生是必需的。 ROS。这些结果表明,ACE抑制剂可在COPD患者中充当肺抗氧化剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号